Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

DORAYA-HF Early Feasibility Study

NCT: NCT05206422 · COMPLETED

NCT IDNCT05206422
StatusCOMPLETED
Start Date2022-10-05
Completion2026-01-31
SponsorRevamp Medical Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

The study objective is to evaluate the feasibility of the Doraya Catheter and measure clinical performance and safety endpoints, in ADHF patients deemed to have insufficient diuretic response.

Frequently Asked Questions

What is DORAYA-HF Early Feasibility Study?

DORAYA-HF Early Feasibility Study is a clinical trial registered under NCT05206422. Current status: COMPLETED.

What is the status of NCT05206422?

The current status of NCT05206422 (DORAYA-HF Early Feasibility Study) is: COMPLETED.

When did DORAYA-HF Early Feasibility Study start?

DORAYA-HF Early Feasibility Study started on 2022-10-05.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.